Document is current
Any future updates will be listed below
-
Authors
Vlasova, K. Yu.
Kerr, A.
Pennock, N. D. https://orcid.org/0000-0001-5374-7843
Jozic, A. https://orcid.org/0000-0001-6249-2328
Sahel, D. K.
Gautam, M. https://orcid.org/0000-0002-3817-620X
Murthy, N. T. V.
Roberts, A.
Ali, M. W.
MacDonald, K. D. https://orcid.org/0000-0002-6716-8559
Walker, J. M.
Luxenhofer, R. https://orcid.org/0000-0001-5567-7404
Sahay, G. https://orcid.org/0000-0003-1071-0500
-
Funding
Funding for this research was provided by:
Cystic Fibrosis Foundation (SAHAY19XX0)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL146736, R01CA270783-01)
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 11 April 2025
First Online: 29 April 2025
Competing interests
: K.Y.V., A.K., M.G., M.W.A., R.L., G.S. have filed a provisional patent based on this work. G.S. is a co-founder of EnterX Bio and has an advisory role to Rare Air Inc., Serina Tx and Mana Bio. The remaining authors declare no competing interests.
